The main causes of iron deficiency (ID) are briefly discussed, followed by the examination of studies of ID and child cognitive and motor development and behaviour for evidence of a causal link, classifying them by study design. Iron deficiency anaemia (IDA) is associated with many psychosocial and economic disadvantages that can affect child development and could explain the frequently demonstrated relationship between IDA and poor development and behavioural differences. There is evidence of changes to brain function in infants with IDA. Many treatment trials lack statistical power due to small samples, including children without ID in the sampling or iron treatment resulting in little or no differences in iron status between placebo and treated groups. In children with IDA under 3 years, randomized trials indicate that iron supplementation is usually beneficial to motor development, but the effect on mental development is inconsistent. Iron supplementation also has a beneficial effect on cognitive function in school-aged children with IDA. Evidence for a threshold level of ID at which child development is affected is inconsistent, but children with IDA are most likely to benefit from iron supplementation. Possible harmful effects of iron supplementation in iron-replete children on growth and morbidity have to be considered when developing programmes and policy.

Keywords:
Child development, Cognition, Motor development, Iron deficiency anaemia
This content is only available via PDF.
© 2010 Nestec Ltd., Vevey/S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.